Research & Development Center
Where Science Meets Hope
We do our best and use our resources to create innovations
Team
Our international science team is a diverse group of skilled experts from all over the world committed to pushing the boundaries of research and innovation to improve healthcare outcomes.
Facility
Our state-of-the-art facility is equipped with cutting-edge technology, providing an optimal environment for research, development, and production in the biopharmaceutical field.
Technology
In our Technology section, explore how we manufacture biosimilar vaccines and integrate monoclonal antibodies into groundbreaking medical treatments. This dual-focus approach is key to our commitment to innovate and improve healthcare outcomes.
Vaccine
Vaccines help protect people from infectious diseases at every stage of life. We manufacture biosimilar vaccines to help people to protect against pneumococcal, meningococcus, HPV, influenza, shingles infections, and even more. We use various platform technologies from adjuvants that bring the most effective vaccines.
Oncology
We develop cancer medicines with promising technology mAb to treat melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, stomach cancer, cervical cancer, and certain types of breast cancer.
Gene Therapy
Personalized medicine is the future of all disease treatment, and gene therapy, one of the most promising approaches, will revolutionize this field. Based on lenti and adeno platform technologies, our teams develop one of the best ways to treat lymphoma, leukemia, and multiple myeloma.
Pipeline
As a committed biopharma company, we determine our pipeline of potential vaccines and medicines to clarify what is about to develop and what must come true.
Molecule Name
ОВР-2201
ОВР-2311
Therapeutic Area
Oncology
Oncology
Potential Indications
Different Types of B-cell lymphoma
Melanoma, Non-Small Cell Lung Cancer, Head & Neck Squamous Cell Carcinoma, Classical Hodgkin Lymphoma, Primary Mediastinal Large B-Cell Lymphoma, Urothelial Carcinoma, Microsatellite Instability-High Cancer
Status
Development
Development
Modality
Gene Therapy
Monocloncal Antibody
Tech Partners
